Salarius Pharmaceuticals (SLRX) SEC Filings & 10K Form

$1.45

-0.03 (-2.03%)

(As of 11/4/2024 ET)

Compare

Recent Salarius Pharmaceuticals SEC Filings

Filing Types

Ownership Filings

Time Frame

Start Date

End Date

Export to Excel

Date	Filer	Form Type
11/01/2024 4:05 PM	Salarius Pharmaceuticals, Inc. (Filer) Salarius Pharmaceuticals (Filer)	Form DEFA14A
11/01/2024 4:04 PM	Salarius Pharmaceuticals, Inc. (Filer) Salarius Pharmaceuticals (Filer)	Form DEF 14A
09/27/2024 3:01 PM	Salarius Pharmaceuticals, Inc. (Filer) Salarius Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
08/09/2024 4:10 PM	Salarius Pharmaceuticals, Inc. (Filer) Salarius Pharmaceuticals (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)
07/25/2024 4:01 PM	Salarius Pharmaceuticals, Inc. (Filer) Salarius Pharmaceuticals (Filer)	Form 424B5
07/25/2024 4:03 PM	Salarius Pharmaceuticals, Inc. (Filer) Salarius Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
07/22/2024 4:25 PM	Salarius Pharmaceuticals, Inc. (Filer) Salarius Pharmaceuticals (Filer)	Form 424B5
07/19/2024 4:13 PM	Salarius Pharmaceuticals, Inc. (Filer) Salarius Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
07/11/2024 7:15 AM	Salarius Pharmaceuticals, Inc. (Filer) Salarius Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
06/17/2024 7:05 AM	Salarius Pharmaceuticals, Inc. (Filer) Salarius Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
06/17/2024 7:11 AM	Salarius Pharmaceuticals, Inc. (Filer) Salarius Pharmaceuticals (Filer)	Form 424B5
04/12/2024 3:50 PM	Arthur David J. (Reporting) Salarius Pharmaceuticals, Inc. (Issuer) Salarius Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
03/26/2024 3:03 PM	Salarius Pharmaceuticals, Inc. (Filer) Salarius Pharmaceuticals (Filer)	Form DEF 14A
03/26/2024 3:05 PM	Salarius Pharmaceuticals, Inc. (Filer) Salarius Pharmaceuticals (Filer)	Form DEFA14A
03/15/2024 4:00 PM	Salarius Pharmaceuticals, Inc. (Filer) Salarius Pharmaceuticals (Filer)	Form PRE 14A
02/22/2024 3:16 PM	Lammers Paul (Reporting) Salarius Pharmaceuticals, Inc. (Issuer) Salarius Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
02/22/2024 3:21 PM	Lieber Jonathan I (Reporting) Salarius Pharmaceuticals, Inc. (Issuer) Salarius Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities

(Data available from 1/1/2016 forward)

Related Companies and Tools

Related Companies

SEC Filings Tools

This page (NASDAQ:SLRX) was last updated on 11/4/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Salarius Pharmaceuticals (SLRX) SEC Filings & 10K Form

Recent Salarius Pharmaceuticals SEC Filings

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Salarius Pharmaceuticals (SLRX) SEC Filings & 10K Form

Recent Salarius Pharmaceuticals SEC Filings

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools